Astech appoints business development manager
Astech Projects has boosted its sales team with the appointment of John Roberts as business development manager.
Roberts has more than 15 years' experience in the packaging industry and the Runcorn supplier of automation products hopes to use this to establish the company as a world class systems integrator within these specialised markets.
You may also like
Regulatory
![Pheno Therapeutics gains FDA IND clearance for first-in-class GPR17 antagonist PTD802 in MS]()
Pheno Therapeutics gains FDA IND clearance for first-in-class GPR17 antagonist PTD802 in MS
The clearance enables a first-in-human trial of the UCB-licensed remyelination candidate, marking the first GPR17 programme to reach clinical development for multiple sclerosis and related demyelinating diseases
Regulatory
![NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development]()
NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development
The discussion underscored the growing importance of aligning employee behaviours with compliance objectives, while also addressing the industry’s ongoing challenges around regulatory benchmarking and operational consistency
Regulatory
![FDA approves Utebzi, first oral carbapenem antibiotic, for complicated UTIs]()
FDA approves Utebzi, first oral carbapenem antibiotic, for complicated UTIs
GSK and Spero Therapeutics' tebipenem pivoxil matches IV imipenem-cilastatin in Phase III trials, offering an outpatient alternative for resistant infections that cost the US healthcare system more than $6bn annually
Hi Tech Manufacturing
![Lonza and Antharis Therapeutics ink licensing deal for dual-payload ADCs targeting GI cancers]()
Lonza and Antharis Therapeutics ink licensing deal for dual-payload ADCs targeting GI cancers
Antharis gains rights to Lonza's clinically validated dual-payload technology, combining it with proprietary antibody engineering to advance a lead ADC programme entering clinical trials for gastrointestinal cancers
